Sequoia Financial Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,113
Closed -$19.2K 1926
2025
Q4
$19.2K Buy
1,113
+8
+0.7% +$155 ﹤0.01% 1915
2025
Q3
$28.5K Buy
1,105
+3
+0.3% +$113 ﹤0.01% 1727
2025
Q2
$63.4K Hold
1,102
﹤0.01% 1550
2025
Q1
$119K Buy
1,102
+4
+0.4% +$348 ﹤0.01% 1315
2024
Q4
$52.2K Hold
1,098
﹤0.01% 1311
2024
Q3
$108K Hold
1,098
﹤0.01% 1223
2024
Q2
$180K Sell
1,098
-4
-0.4% -$570 ﹤0.01% 1117
2024
Q1
$168K Sell
1,102
-1
-0.1% -$166 ﹤0.01% 1077
2023
Q4
$346K Hold
1,103
﹤0.01% 866
2023
Q3
$490K Buy
1,103
+1
+0.1% +$452 0.01% 532
2023
Q2
$478K Buy
1,102
+1
+0.1% +$562 0.01% 539
2023
Q1
$654K Buy
1,101
+3
+0.3% +$1.68K 0.01% 402
2022
Q4
$443K Buy
+1,098
New +$515K 0.01% 468

Other funds holding AGL

Sequoia Financial Advisors's AGL Position: Q1 2026 in Review

Sequoia Financial Advisors sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 1,113 shares — an estimated $19.2K sold.

Sequoia Financial Advisors first reported a position in AGL in Q4 2022 and held it in 13 quarters. The position peaked at $654K in Q1 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Sequoia Financial Advisors reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Sequoia Financial Advisors sold 1,113 Agilon Health shares in Q1 2026, an estimated $19.2K.
  • Sequoia Financial Advisors first reported a position in Agilon Health in Q4 2022 and held it in 13 quarters.
  • Sequoia Financial Advisors's Agilon Health position peaked at $654K in Q1 2023.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Sequoia Financial Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.